Evidence map›Paper›PMID 35332095›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022

Synthesis and Preclinical Evaluation of

Miho Shukuri, Aya Mawatari, Shuhei Takatani, Tsuyoshi Tahara, Michiko Inoue, Wakiko Arakaki, Masahiro Ohno, Hisashi Doi, Hirotaka Onoe

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Miho ShukuriLaboratory of Physical Chemistry, Showa Pharmaceutical University, Tokyo, Japan.
Aya MawatariLaboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research, Hyogo, Japan.
Shuhei TakataniLaboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research, Hyogo, Japan.
Tsuyoshi TaharaLaboratory for Biofunction Dynamics Imaging, RIKEN Center for Biosystems Dynamics Research, Hyogo, Japan.
Michiko InoueLaboratory for Biofunction Dynamics Imaging, RIKEN Center for Biosystems Dynamics Research, Hyogo, Japan.
Wakiko ArakakiLaboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research, Hyogo, Japan.
Masahiro OhnoLaboratory for Brain Connectomics Imaging, RIKEN Center for Biosystems Dynamics Research, Hyogo, Japan; and.
Hisashi DoiLaboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research, Hyogo, Japan; hisashi.doi@riken.jp h_onoe@kuhp.kyoto-u.ac.jp.
Hirotaka OnoeHuman Brain Research Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan hisashi.doi@riken.jp h_onoe@kuhp.kyoto-u.ac.jp.
RIKEN Center for Biosystems Dynamics Research · JPKyoto University · JPShowa Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclooxygenase (COX) is a rate-limiting enzyme in the synthesis of proinflammatory prostanoids from arachidonic acid. In vivo imaging of COX by PET is a potentially powerful tool for assessing the inflammatory response to injury, infection, and disease. We previously reported on a promising PET probe for COX imaging,

Indexed as

Cyclooxygenase 1KetoprofenAnimalsNeuroinflammatory DiseasesPositron-Emission TomographyRadiopharmaceuticalsRatsCyclooxygenase 1Ketoprofenketoprofen methyl esterRadiopharmaceuticals[18F]FKTP-MeCOX-1neuroinflammationPET

Identifiers

PMID35332095
PMCPMC9635687
OpenAlexW4220827125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.